Cargando…
S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain
Ca2(+)-binding human S100A1 protein is a type of S100 protein. S100A1 is a significant mediator during inflammation when Ca(2+) binds to its EF-hand motifs. Receptors for advanced glycation end products (RAGE) correspond to 5 domains: the cytoplasmic, transmembrane, C2, C1, and V domains. The V doma...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812564/ https://www.ncbi.nlm.nih.gov/pubmed/29444082 http://dx.doi.org/10.1371/journal.pone.0190545 |
_version_ | 1783300047888187392 |
---|---|
author | Khan, Md. Imran Su, Yu-Kai Zou, Jinhao Yang, Lee-Wei Chou, Ruey-Hwang Yu, Chin |
author_facet | Khan, Md. Imran Su, Yu-Kai Zou, Jinhao Yang, Lee-Wei Chou, Ruey-Hwang Yu, Chin |
author_sort | Khan, Md. Imran |
collection | PubMed |
description | Ca2(+)-binding human S100A1 protein is a type of S100 protein. S100A1 is a significant mediator during inflammation when Ca(2+) binds to its EF-hand motifs. Receptors for advanced glycation end products (RAGE) correspond to 5 domains: the cytoplasmic, transmembrane, C2, C1, and V domains. The V domain of RAGE is one of the most important target proteins for S100A1. It binds to the hydrophobic surface and triggers signaling transduction cascades that induce cell growth, cell proliferation, and tumorigenesis. We used nuclear magnetic resonance (NMR) spectroscopy to characterize the interaction between S100A1 and the RAGE V domain. We found that S100B could interact with S100A1 via NMR (1)H-(15)N HSQC titrations. We used the HADDOCK program to generate the following two binary complexes based on the NMR titration results: S100A1-RAGE V domain and S100A1-S100B. After overlapping these two complex structures, we found that S100B plays a crucial role in blocking the interaction site between RAGE V domain and S100A1. A cell proliferation assay WST-1 also supported our results. This report could potentially be useful for new protein development for cancer treatment. |
format | Online Article Text |
id | pubmed-5812564 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-58125642018-02-28 S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain Khan, Md. Imran Su, Yu-Kai Zou, Jinhao Yang, Lee-Wei Chou, Ruey-Hwang Yu, Chin PLoS One Research Article Ca2(+)-binding human S100A1 protein is a type of S100 protein. S100A1 is a significant mediator during inflammation when Ca(2+) binds to its EF-hand motifs. Receptors for advanced glycation end products (RAGE) correspond to 5 domains: the cytoplasmic, transmembrane, C2, C1, and V domains. The V domain of RAGE is one of the most important target proteins for S100A1. It binds to the hydrophobic surface and triggers signaling transduction cascades that induce cell growth, cell proliferation, and tumorigenesis. We used nuclear magnetic resonance (NMR) spectroscopy to characterize the interaction between S100A1 and the RAGE V domain. We found that S100B could interact with S100A1 via NMR (1)H-(15)N HSQC titrations. We used the HADDOCK program to generate the following two binary complexes based on the NMR titration results: S100A1-RAGE V domain and S100A1-S100B. After overlapping these two complex structures, we found that S100B plays a crucial role in blocking the interaction site between RAGE V domain and S100A1. A cell proliferation assay WST-1 also supported our results. This report could potentially be useful for new protein development for cancer treatment. Public Library of Science 2018-02-14 /pmc/articles/PMC5812564/ /pubmed/29444082 http://dx.doi.org/10.1371/journal.pone.0190545 Text en © 2018 Khan et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Khan, Md. Imran Su, Yu-Kai Zou, Jinhao Yang, Lee-Wei Chou, Ruey-Hwang Yu, Chin S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain |
title | S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain |
title_full | S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain |
title_fullStr | S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain |
title_full_unstemmed | S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain |
title_short | S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain |
title_sort | s100b as an antagonist to block the interaction between s100a1 and the rage v domain |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812564/ https://www.ncbi.nlm.nih.gov/pubmed/29444082 http://dx.doi.org/10.1371/journal.pone.0190545 |
work_keys_str_mv | AT khanmdimran s100basanantagonisttoblocktheinteractionbetweens100a1andtheragevdomain AT suyukai s100basanantagonisttoblocktheinteractionbetweens100a1andtheragevdomain AT zoujinhao s100basanantagonisttoblocktheinteractionbetweens100a1andtheragevdomain AT yangleewei s100basanantagonisttoblocktheinteractionbetweens100a1andtheragevdomain AT chourueyhwang s100basanantagonisttoblocktheinteractionbetweens100a1andtheragevdomain AT yuchin s100basanantagonisttoblocktheinteractionbetweens100a1andtheragevdomain |